Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Oct. 31, 2024	Apr. 30, 2024
Current assets:
Cash and cash equivalents	$ 41,581	$ 31,789
Marketable securities	94,195	178,612
Research and development tax credit receivable	11,082	8,439
Prepaid expenses and other current assets	5,409	6,850
Total current assets	152,267	225,690
Property and equipment, net	2,039	2,227
Right of use assets	5,863	6,920
Other assets	662	567
Total assets	160,831	235,404
Current liabilities:
Accounts payable	5,198	9,107
Accrued expenses	15,429	12,398
Lease liability - current portion	1,537	1,302
Total current liabilities	22,164	22,807
Long-term liabilities:
Lease liability - net of current portion	4,675	6,015
Total long-term liabilities	4,675	6,015
Commitments and contingencies (Note 6)
Stockholders’ equity
Common stock, $0.001 par value, 100,000,000 authorized Shares issued and outstanding: 43,271,501 at October 31, 2024 and 42,521,975 at April 30, 2024	43	42
Additional paid-in capital	689,087	679,754
Accumulated deficit	(552,437)	(469,726)
Accumulated other comprehensive loss	(2,701)	(3,488)
Total stockholders’ equity	133,992	206,582
Total liabilities and stockholders’ equity	$ 160,831	$ 235,404